Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T15377 | Target Info | |||
Target Name | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (ATP2A2) | ||||
Synonyms |
SR Ca(2+)Sarcoplasmic/endoplasmic reticulum calcium ATPase 2-ATPase 2; SR Ca(2+)-ATPase 2; SR Ca(2+)-ATPase; SR Ca(2+) pump; SERCA2; Endoplasmic reticulum class 1/2 Ca(2+) ATPase; Cardiacsarcoplasmic reticulum calcium ATPase; CardiacCa2+ ATPase (SERCA2a); Calciumpump 2; Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform; Calcium pump 2; ATP2B
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | ATP2A2 | ||||
Biochemical Class | Cation transporting ATPase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Voltage-gated calcium channel alpha Cav1.2 (CACNA1C) | Successful Target | ||||
UniProt ID | CAC1C_HUMAN | |||||
Gene Name | CACNA1C | |||||
Synonyms |
Voltage-gated calcium channel subunit alpha Cav1.2; Voltage-dependent L-type calcium channel subunit alpha-1C; Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle; CCHL1A1; CACNL1A1; CACN2; CACH2
Click to Show/Hide
|
|||||
Representative Drug(s) | Gallopamil | Drug Info | IC50 = 17 nM | [1] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. J Appl Toxicol. 2012 Oct;32(10):858-66. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.